Hanna TP - Search Results

1

A perspective on life-cycle health technology assessment and real-world evidence for precision oncology in Canada.

Regier DA, Pollard S, McPhail M, Bubela T, Hanna TP, Ho C, Lim HJ, Chan K, Peacock SJ, Weymann D. Regier DA, et al. Among authors: hanna tp. NPJ Precis Oncol. 2022 Oct 25;6(1):76. doi: 10.1038/s41698-022-00316-1. NPJ Precis Oncol. 2022. PMID: 36284134 Free PMC article. Review.

2

Real-world comparative effectiveness of second-line ipilimumab for metastatic melanoma: a population-based cohort study in Ontario, Canada.

Dai WF, Beca JM, Croxford R, Isaranawatchai W, Menjak IB, Petrella TM, Mittmann N, Earle CC, Gavura S, Hanna TP, Chan KKW. Dai WF, et al. Among authors: hanna tp. BMC Cancer. 2020 Apr 15;20(1):304. doi: 10.1186/s12885-020-06798-1. BMC Cancer. 2020. PMID: 32293341 Free PMC article. Clinical Trial.

3

Real-world, population-based cohort study of toxicity and resource utilization of second-line ipilimumab for metastatic melanoma in Ontario, Canada.

Dai WF, Beca J, Croxford R, Isaranuwatchai W, Menjak IB, Petrella TM, Mittmann N, Earle CC, Gavura S, Mercer RE, Hanna TP, Chan KKW. Dai WF, et al. Among authors: hanna tp. Int J Cancer. 2021 Apr 15;148(8):1910-1918. doi: 10.1002/ijc.33357. Epub 2020 Nov 7. Int J Cancer. 2021. PMID: 33105030 Free article.

4

Defining a Core Data Set for the Economic Evaluation of Precision Oncology.

Pollard S, Weymann D, Chan B, Ehman M, Wordsworth S, Buchanan J, Hanna TP, Ho C, Lim HJ, Lorgelly PK, Raymakers AJN, McCabe C, Regier DA. Pollard S, et al. Among authors: hanna tp. Value Health. 2022 Aug;25(8):1371-1380. doi: 10.1016/j.jval.2022.01.005. Epub 2022 Feb 23. Value Health. 2022. PMID: 35216902 Free article. Review.

5

The risk of contracting SARS-CoV-2 or developing COVID-19 for people with cancer: A systematic review of the early evidence.

Carle C, Hughes S, Freeman V, Campbell D, Egger S, Caruana M, Hui H, Yap S, Deandrea S, Onyeka TC, IJzerman MJ, Ginsburg O, Bray F, Sullivan R, Aggarwal A, Peacock SJ, Chan KKW, Hanna TP, Soerjomataram I, O'Connell DL, Canfell K, Steinberg J. Carle C, et al. Among authors: hanna tp. J Cancer Policy. 2022 Sep;33:100338. doi: 10.1016/j.jcpo.2022.100338. Epub 2022 Jun 6. J Cancer Policy. 2022. PMID: 35671919 Free PMC article. Review.

6

Are patients with cancer at higher risk of COVID-19-related death? A systematic review and critical appraisal of the early evidence.

Freeman V, Hughes S, Carle C, Campbell D, Egger S, Hui H, Yap S, Deandrea S, Caruana M, Onyeka TC, IJzerman MJ, Ginsburg O, Bray F, Sullivan R, Aggarwal A, Peacock SJ, Chan KKW, Hanna TP, Soerjomataram I, O'Connell DL, Steinberg J, Canfell K. Freeman V, et al. Among authors: hanna tp. J Cancer Policy. 2022 Sep;33:100340. doi: 10.1016/j.jcpo.2022.100340. Epub 2022 Jun 6. J Cancer Policy. 2022. PMID: 35680113 Free PMC article. Review.

7

Imaging and physician visits at cancer diagnosis: COVID -19 pandemic impact on cancer care.

Fu R, Sutradhar R, Li Q, Hanna TP, Chan KKW, Coburn N, Hallet J, Eskander A; Pandemic-Ontario Collaborative in Cancer Research (POCCR). Fu R, et al. Among authors: hanna tp. Cancer Med. 2023 Mar;12(5):6056-6067. doi: 10.1002/cam4.5321. Epub 2022 Sep 29. Cancer Med. 2023. PMID: 36176264 Free PMC article.

8

Cost-effectiveness of second-line ipilimumab for metastatic melanoma: A real-world population-based cohort study of resource utilization.

Lu B, Dai WF, Croxford R, Isaranuwatchai W, Beca J, Menjak IB, Petrella TM, Mittmann N, Earle CC, Gavura S, Mercer RE, Hanna TP, Chan KKW. Lu B, et al. Among authors: hanna tp. Cancer Med. 2023 May;12(10):11451-11461. doi: 10.1002/cam4.5862. Epub 2023 Mar 31. Cancer Med. 2023. PMID: 36999965 Free PMC article.

9

Augmenting clinical trial economic analysis by linking cancer trial data to administrative data: current landscape and future opportunities.

Wilson BE, Hay AE, Chan KK, Cheung MC, Hanna TP. Wilson BE, et al. Among authors: hanna tp. BMJ Open. 2023 Aug 11;13(8):e073353. doi: 10.1136/bmjopen-2023-073353. BMJ Open. 2023. PMID: 37567744 Free PMC article. Review.

10

Changes in Health Care Costs, Survival, and Time Toxicity in the Era of Immunotherapy and Targeted Systemic Therapy for Melanoma.

Bateni SB, Nguyen P, Eskander A, Seung SJ, Mittmann N, Jalink M, Gupta A, Chan KKW, Look Hong NJ, Hanna TP. Bateni SB, et al. Among authors: hanna tp. JAMA Dermatol. 2023 Nov 1;159(11):1195-1204. doi: 10.1001/jamadermatol.2023.3179. JAMA Dermatol. 2023. PMID: 37672282 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

106 results

Search Page